RCM
ETRM

Rotella Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Rotella Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-18
Closed -$18K – 727
2015
Q1 		$18K Sell
18
-5
-22% -$6.03K 0.02% 496
2014
Q4 		$35K Sell
23
-2
-8% -$2.7K 0.03% 322
2014
Q3 		$33K Sell
25
-41
-62% -$60.1K 0.03% 273
2014
Q2 		$108K Buy
+66
New +$123K 0.09% 207

Other funds holding ETRM

TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Rotella Capital Management's ETRM Position: Q2 2015 in Review

Rotella Capital Management sold out of EnteroMedics Inc. (ETRM) in Q2 2015, closing a stake of 18 shares — an estimated $18K sold.

Rotella Capital Management first reported a position in ETRM in Q2 2014 and held it in 4 quarters. The position peaked at $108K in Q2 2014. 46 funds tracked by Wall St. Rank hold ETRM as of Q2 2015.

  • Rotella Capital Management reported no remaining EnteroMedics Inc. position as of Q2 2015 after selling out during the quarter.
  • Rotella Capital Management sold 18 EnteroMedics Inc. shares in Q2 2015, an estimated $18K.
  • Rotella Capital Management first reported a position in EnteroMedics Inc. in Q2 2014 and held it in 4 quarters.
  • Rotella Capital Management's EnteroMedics Inc. position peaked at $108K in Q2 2014.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2015.

Based on Rotella Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.